You are here

basal insulin

Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win

Fierce Biotech

Wed, 10/5/22 - 07:11 pm

Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus

Fierce Pharma

Thu, 12/13/18 - 12:24 pm

Boehringer Ingelheim

Novo Basal Insulin Gets CHMP Nod to Update Label

Investopedia

Sat, 03/25/17 - 12:15 pm

Eli Lilly wins label expansion for Trulicity injection with basal insulin

Endpoints

Wed, 02/8/17 - 09:39 pm

Lilly stops development of diabetes treatment

Yahoo/Reuters

Fri, 12/4/15 - 01:55 pm

Lilly says peglispro is superior to Sanofi's Lantus

Medical Marketing and Media

Mon, 06/8/15 - 10:02 pm

Lilly peglispro delay may be boon for its biosimilar

Medical Marketing and Media

Mon, 02/23/15 - 05:54 pm

Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro

Yahoo

Mon, 02/23/15 - 09:45 am

Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues

Bidness Etc.

Mon, 10/6/14 - 11:51 am